APA (7th ed.) Citation
(2026). RIPK3 inhibitor GSK872 targets angiotensin II induced cardiomyocyte hypertrophy by regulating Ca2+/ calmodulin dependent protein kinase II. PLOS ONE.
Chicago Style (17th ed.) Citation
"RIPK3 Inhibitor GSK872 Targets Angiotensin II Induced Cardiomyocyte Hypertrophy by Regulating Ca2+/ Calmodulin Dependent Protein Kinase II." PLOS ONE 2026.
MLA (9th ed.) Citation
"RIPK3 Inhibitor GSK872 Targets Angiotensin II Induced Cardiomyocyte Hypertrophy by Regulating Ca2+/ Calmodulin Dependent Protein Kinase II." PLOS ONE, 2026.
Warning: These citations may not always be 100% accurate.